LIM/49 - Laboratório de Protozoologia

O Laboratório de Protozoologia é ligado ao Departamento de Moléstias Infecciosas e Parasitárias da Faculdade de Medicina da Universidade de São Paulo (FMUSP).

Linhas de pesquisa: protozoologia humana e estudo das grandes endemias, como malária, leishmaniose, a tripanossomíase americana, a toxoplasmose e outras, nos seus aspectos epidemiológicos, parasitológicos, moleculares, diagnósticos, clínicos, de intervenções terapêuticas, vacinas e controle de vetores, através de estudos experimentais, hospitalares ou de campo nas áreas de maior ocorrência do país e do exterior.

Site oficial: http://limhc.fm.usp.br/portal/lim49-laboratorio-de-protozoologia/

Navegar

Novos documentos depositados

  1. Early clinical and microbiological predictors of outcome in hospitalized patients with cryptococcal meningitis

    BMC INFECTIOUS DISEASES, v.22, n.1, article ID 138, 14p, 2022

    Background Cryptococcal meningitis causes high mortality in immunocompromised and immunocompetent patients. The objective of this study was to identify early predictors of clinical outcome, available at the first days of hospitalization, in patients with cryptococcal meningitis in a tertiary cent...

  2. Ivermectin for the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-analysis of Randomized Controlled Trials

    CLINICAL INFECTIOUS DISEASES, v.74, n.6, p.1022-1029, 2022

    Our systematic review of randomized controlled trials showed that ivermectin (vs control) did not reduce all-cause mortality, hospital stays, or viral clearance in patients with mostly mild coronavirus disease 2019 (COVID-19). Ivermectin is not a viable treatment option for COVID-19. Background W...

  3. Reply to Banno et al and Padhi et al

    CLINICAL INFECTIOUS DISEASES, v.74, n.6, p.1122-1123, 2022

  4. An algorithm based on molecular protocols to improve the detection of Plasmodium in autochthonous malarial areas in the Atlantic Forest biome

    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, v.64, article ID e18, 10p, 2022

    Malaria is the most important vector-borne disease in the world and a challenge for control programs. In Brazil, 99% of cases occur in the Amazon region. In the extra-Amazonian region, a non-endemic area, epidemiological surveillance focuses on imported malaria and on autochthonous outbreaks, inc...

  5. Efficiency of a Single well IgG, IgM and IgA Anti T. gondii Fluorimetric Assay for Pre-natal Screening for Congenital Toxoplasmosis

    JOURNAL OF FLUORESCENCE, v.32, n.2, p.661-667, 2022

    Toxoplasmosis, worldwide protozoan disease, is usually benign, except when acute disease occurs in pregnant women, resulting in fetal infection with deaths or high morbidity after birth. Treatment blocks fetal infection or damage after infection, imposing a quick and effective diagnosis. Maternal...

  6. Fake news and covid-19: a concern due to the low vaccine coverage in Brazil

    SAUDE E SOCIEDADE, v.31, n.1, article ID e210298, 11p, 2022

    This study comprised the application of a survey in Sao Paulo, Brazil, in 2 different periods of 2020: the beginning of the covid-19 pandemic and the disease's first peak (from March to April, 100 interviews) to the time of stability in case fatality rates (from May to July, 100 interviews); the ...

  7. Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil

    AMERICAN JOURNAL OF INFECTION CONTROL, v.50, n.2, p.238-239, 2022

  8. Identification of Leishmania species by next generation sequencing of hsp70 gene

    MOLECULAR AND CELLULAR PROBES, v.61, article ID 101791, 5p, 2022

    Leishmaniasis is a major public health problem worldwide. Although next generation sequencing technology has been widely used in the diagnosis of infectious diseases, it has been scarcely applied in identification of Leishmania species. The aim of this study was to compare the efficiency of MinIO...

  9. Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: A prospective cohort study of vaccinated and unvaccinated healthcare workers

    JOURNAL OF INFECTION, v.84, n.2, p.262-265, 2022

  10. MALDI-TOF mass spectrometry of saliva samples as a prognostic tool for COVID-19

    JOURNAL OF ORAL MICROBIOLOGY, v.14, n.1, article ID 2043651, 12p, 2022

    Background The SARS-CoV-2 infections are still imposing a great public health challenge despite the recent developments in vaccines and therapy. Searching for diagnostic and prognostic methods that are fast, low-cost and accurate are essential for disease control and patient recovery. The MALDI-T...